S&P 500   3,367.49 (-0.37%)
DOW   29,202.51 (-0.67%)
QQQ   234.45 (-0.08%)
AAPL   317.81 (-2.20%)
FB   217.35 (+1.48%)
MSFT   186.99 (+0.88%)
AMZN   2,155.86 (+0.98%)
CGC   22.41 (+1.26%)
BABA   219.06 (-0.26%)
MU   57.93 (-0.99%)
AMD   57.89 (+4.66%)
T   38.22 (-0.08%)
ACB   1.63 (+3.16%)
F   8.05 (-0.62%)
BAC   34.26 (-1.69%)
GILD   67.01 (-0.83%)
S&P 500   3,367.49 (-0.37%)
DOW   29,202.51 (-0.67%)
QQQ   234.45 (-0.08%)
AAPL   317.81 (-2.20%)
FB   217.35 (+1.48%)
MSFT   186.99 (+0.88%)
AMZN   2,155.86 (+0.98%)
CGC   22.41 (+1.26%)
BABA   219.06 (-0.26%)
MU   57.93 (-0.99%)
AMD   57.89 (+4.66%)
T   38.22 (-0.08%)
ACB   1.63 (+3.16%)
F   8.05 (-0.62%)
BAC   34.26 (-1.69%)
GILD   67.01 (-0.83%)
S&P 500   3,367.49 (-0.37%)
DOW   29,202.51 (-0.67%)
QQQ   234.45 (-0.08%)
AAPL   317.81 (-2.20%)
FB   217.35 (+1.48%)
MSFT   186.99 (+0.88%)
AMZN   2,155.86 (+0.98%)
CGC   22.41 (+1.26%)
BABA   219.06 (-0.26%)
MU   57.93 (-0.99%)
AMD   57.89 (+4.66%)
T   38.22 (-0.08%)
ACB   1.63 (+3.16%)
F   8.05 (-0.62%)
BAC   34.26 (-1.69%)
GILD   67.01 (-0.83%)
S&P 500   3,367.49 (-0.37%)
DOW   29,202.51 (-0.67%)
QQQ   234.45 (-0.08%)
AAPL   317.81 (-2.20%)
FB   217.35 (+1.48%)
MSFT   186.99 (+0.88%)
AMZN   2,155.86 (+0.98%)
CGC   22.41 (+1.26%)
BABA   219.06 (-0.26%)
MU   57.93 (-0.99%)
AMD   57.89 (+4.66%)
T   38.22 (-0.08%)
ACB   1.63 (+3.16%)
F   8.05 (-0.62%)
BAC   34.26 (-1.69%)
GILD   67.01 (-0.83%)
Log in

Agios Pharmaceuticals Earnings Date, Estimates & History (NASDAQ:AGIO)

$52.28
+0.77 (+1.49 %)
(As of 02/18/2020 01:16 PM ET)
Today's Range
$51.22
Now: $52.28
$52.43
50-Day Range
$45.32
MA: $50.11
$53.81
52-Week Range
$28.36
Now: $52.28
$68.94
Volume219,453 shs
Average Volume565,319 shs
Market Capitalization$3.08 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.42

Earnings

Agios Pharmaceuticals (NASDAQ:AGIO) Earnings Information

Agios Pharmaceuticals last issued its earnings results on February 13th, 2020. The biopharmaceutical company reported ($1.60) EPS for the quarter, topping analysts' consensus estimates of ($1.72) by $0.12. The firm had revenue of $35.44 million for the quarter, compared to analyst estimates of $33.72 million. Its quarterly revenue was up 18.1% on a year-over-year basis. Agios Pharmaceuticals has generated ($6.86) earnings per share over the last year. Agios Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 7th, 2020 based off prior year's report dates.

Agios Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Agios Pharmaceuticals (NASDAQ:AGIO) Earnings Estimates

2020 EPS Consensus Estimate: ($6.94)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($1.85)($1.53)($1.69)
Q2 20202($1.95)($1.55)($1.75)
Q3 20202($1.90)($1.55)($1.73)
Q4 20202($1.95)($1.60)($1.78)
Q1 20212($1.70)($1.30)($1.50)
Q2 20212($1.80)($1.00)($1.40)
Q3 20212($1.30)($1.09)($1.20)

Agios Pharmaceuticals (NASDAQ AGIO) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/7/2020
(Estimated)
       
2/13/2020Q4 2019($1.72)($1.60)($1.60)$33.72 million$35.44 millionTranscript
10/31/2019Q3 2019($1.85)($1.81)($1.81)$33.13 million$26.02 millionTranscript
8/1/2019Q2 2019($1.70)($1.87)($1.87)$27.05 million$26.22 millionN/A
5/2/20193/31/2019($1.74)($1.59)($1.59)$22.69 million$30.20 millionN/A
2/14/201912/31/2018($1.65)($1.58)($1.58)$19.98 million$30.00 millionListen
11/1/20189/30/2018($1.62)($1.63)($1.63)$22.72 million$15.20 millionN/A
8/2/2018Q2 2018($1.62)($1.19)($1.19)$12.47 million$40.40 millionN/A
5/4/2018Q1 2018($1.60)($1.63)($1.63)$11.93 million$8.80 millionN/A
2/14/2018Q4 2017($1.65)($1.81)($1.81)$12.65 million$9.80 millionTranscript
11/1/2017Q3 2017($1.78)($1.59)($1.59)$10.85 million$11.35 millionN/A
8/8/2017Q2 2017($1.57)($1.78)($1.78)$10.68 million$11.30 millionListen
5/4/2017Q1 2017($1.80)($1.56)($1.56)$9.65 million$10.51 millionListen
2/16/2017Q416($1.51)($1.34)($1.34)$10.89 million$22.65 millionListen
11/3/2016Q316($1.52)($1.63)($1.63)$7.82 million$8.98 millionListen
8/4/2016Q216($0.48)($1.47)($1.47)$39.62 million$6.98 millionListen
5/5/2016Q116($0.79)($0.61)($0.61)$20.94 million$31.30 millionListen
2/18/2016Q415($0.27)($1.08)($1.08)$28.78 million$6.22 millionListen
11/5/2015Q315($0.89)($1.07)($1.07)$17.21 million$5.80 millionListen
8/6/2015Q215($0.46)($0.85)($0.85)$25.75 million$13.20 millionListen
5/7/2015Q115($0.86)($0.13)($0.13)$10.86 million$34.20 millionListen
2/17/2015Q414($0.55)($0.76)($0.76)$10.94 million$14.64 millionListen
11/7/2014Q314($0.53)$0.10$0.10$8.45 million$33.90 millionListen
8/7/2014Q2($0.47)($0.54)($0.54)$11.00 million$8.41 millionListen
5/8/2014Q1($0.37)($0.39)($0.39)$7.19 million$8.41 millionListen
3/6/2014Q4 2013($0.34)($0.40)($0.40)$6.19 million$6.70 millionListen
11/7/2013Q3 2013($0.28)($0.47)($0.47)$6.22 million$6.27 millionListen
9/5/2013Q2 2013($0.28)($2.80)($2.80)$6.19 million$6.27 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/18/2020 by MarketBeat.com Staff

Featured Article: Commodities

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel